{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:25:37Z","timestamp":1792513537693,"version":"4.5.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00569","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T04:18:31Z","timestamp":1553660311000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma\/Delta T Cells Upon Interaction With Tumor Cells"],"prefix":"10.3389","volume":"10","author":[{"given":"Jaydeep","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Dubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Dananberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elgar Susanne","family":"Quabius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Marie","family":"Dowds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guranda","family":"Chitadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Lettau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Kabelitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"B1","first-page":"8","article-title":"NKG2D ligands as therapeutic targets","volume":"13","author":"Spear","year":"2013","journal-title":"Cancer Immun"},{"key":"B2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-3083.2007.01963.x","article-title":"Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor versus NKG2D-dependent recognition","volume":"66","author":"Wrobel","year":"2007","journal-title":"Scand J Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4049\/jimmunol.1000373","article-title":"NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals","volume":"185","author":"Nedellec","year":"2010","journal-title":"J Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1007\/s00018-011-0797-0","article-title":"Regulation of immune cell function and differentiation by the NKG2D receptor","volume":"68","author":"Zafirova","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-07-6768","article-title":"Tumor-associated MICA is shed by ADAM proteases","volume":"68","author":"Waldhauer","year":"2008","journal-title":"Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/ijc.28174","article-title":"Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the \u201ca disintegrin and metalloproteases\u201d 10 and 17","volume":"133","author":"Chitadze","year":"2013","journal-title":"Int J Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.4049\/jimmunol.0903789","article-title":"Wu D. The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases","volume":"184","author":"Liu","year":"2010","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.1258867","article-title":"Antitumor immunity. a shed NKG2D ligand that promotes natural killer cell activation and tumor rejection","volume":"348","author":"Deng","year":"2015","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/cncr.11543","article-title":"Results of decitabine (5-aza-2\u2032 deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia","volume":"98","author":"Kantarjian","year":"2003","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1878-5085-4-5","article-title":"Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?","volume":"4","author":"Mahler","year":"2013","journal-title":"EPMA J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","article-title":"Therapeutic roles of curcumin: lessons learned from clinical trials","volume":"15","author":"Gupta","year":"2013","journal-title":"AAPS J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1634\/theoncologist.2011-0031","article-title":"A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma","volume":"16","author":"Mohammed","year":"2011","journal-title":"Oncologist"},{"key":"B16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cellimm.2015.01.019","article-title":"Modulation of human gamma\/delta T-cell activation and phenotype by histone deacetylase inhibitors","volume":"296","author":"Bhat","year":"2015","journal-title":"Cell Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"64743","DOI":"10.18632\/oncotarget.11462","article-title":"Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma\/delta T-cells","volume":"7","author":"Bhat","year":"2016","journal-title":"Oncotarget"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/bjc.2017.79","article-title":"MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue","volume":"116","author":"Ghadially","year":"2017","journal-title":"Br J Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2141.2008.07435.x","article-title":"Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP\/DMAPP","volume":"144","author":"Roelofs","year":"2009","journal-title":"Br J Haematol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.4049\/jimmunol.175.8.5481","article-title":"V gamma 9V delta 2 T cell response to colon carcinoma cells","volume":"175","author":"Corvaisier","year":"2005","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.4049\/jimmunol.1400920","article-title":"A truncated human NKG2D splice isoform negatively regulates NKG2D-mediated function","volume":"193","author":"Karimi","year":"2014","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/2326-6066.CIR-17-0201","article-title":"Impact of tumor purity on immune gene expression and clustering analyses across multiple cancer types","volume":"6","author":"Rhee","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1360","DOI":"10.7717\/peerj.1360","article-title":"Getting the most out of RNA-seq data analysis","volume":"3","author":"Khang","year":"2015","journal-title":"PeerJ"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2052-8426-2-11","article-title":"Genome-wide analysis of primary peripheral blood mononuclear cells from HIV + patients-pre- and post-HAART show immune activation and inflammation the main drivers of host gene expression","volume":"2","author":"da Conceicao","year":"2014","journal-title":"Mol Cell Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e95347","DOI":"10.1371\/journal.pone.0095347","article-title":"Identification of gene expression changes from colitis to CRC in the mouse CAC model","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1109\/TKDE.2004.68","article-title":"Cluster analysis for gene expression data: a survey","volume":"16","author":"Daxin","year":"2004","journal-title":"IEEE Trans Knowl Data Eng"},{"key":"B29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/73439","article-title":"A gene expression database for the molecular pharmacology of cancer","volume":"24","author":"Scherf","year":"2000","journal-title":"Nat Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/cyto.a.22344","article-title":"The study of epigenetic mechanisms based on the analysis of histone modification patterns by flow cytometry","volume":"85","author":"Watson","year":"2014","journal-title":"Cytometry A"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.4049\/jimmunol.0903830","article-title":"Histone acetylation at the single-cell level: a marker of memory CD8+ T cell differentiation and functionality","volume":"184","author":"Dispirito","year":"2010","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1084\/jem.20030235","article-title":"Differentiation of effector\/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites","volume":"198","author":"Dieli","year":"2003","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/CJI.0b013e31820e1b0d","article-title":"Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer","volume":"34","author":"Huang","year":"2011","journal-title":"J Immunother"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1158\/0008-5472.CAN-04-4252","article-title":"Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate","volume":"65","author":"Armeanu","year":"2005","journal-title":"Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1097\/SLA.0b013e3181758d0e","article-title":"Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells","volume":"247","author":"Greenblatt","year":"2008","journal-title":"Ann Surg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1756-9966-29-149","article-title":"Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line","volume":"29","author":"Yagi","year":"2010","journal-title":"J Exp Clin Cancer Res."},{"key":"B37","first-page":"7","article-title":"Valproic acid suppresses growth and enhances cisplatin cytotoxicity to larynx cancer cells","volume":"6","author":"Graniczka","year":"2014","journal-title":"Head Neck Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3892\/or_00001026","article-title":"Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA\/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity","volume":"24","author":"Yamanegi","year":"2010","journal-title":"Oncol Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1182\/blood-2011-07-370841","article-title":"High ERp5\/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas","volume":"119","author":"Zocchi","year":"2012","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.4049\/jimmunol.0801214","article-title":"Proteasome regulation of ULBP1 transcription","volume":"182","author":"Butler","year":"2009","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1593\/neo.121236","article-title":"Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma","volume":"14","author":"Wu","year":"2012","journal-title":"Neoplasia"},{"key":"B42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/sji.12072","article-title":"Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications","volume":"78","author":"Chitadze","year":"2013","journal-title":"Scand J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/epi.23115","article-title":"DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells","volume":"8","author":"Fernandez-Sanchez","year":"2013","journal-title":"Epigenetics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/infdis\/jis253","article-title":"Phenotypic and functional characterization of human gammadelta T-cell subsets in response to influenza A viruses","volume":"205","author":"Qin","year":"2012","journal-title":"J Infect Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e16700","DOI":"10.1371\/journal.pone.0016700","article-title":"Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model","volume":"6","author":"Siegers","year":"2011","journal-title":"PLoS ONE"},{"key":"B46","first-page":"10","article-title":"Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vgamma9Vdelta2 T cells","volume":"10","author":"Dhar","year":"2010","journal-title":"Cancer Immun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3389\/fimmu.2018.01615","article-title":"Checkpoint Blockade Rescues the Repressive Effect of Histone Deacetylases Inhibitors on gammadelta T Cell Function","volume":"9","author":"Bhat","year":"2018","journal-title":"Front Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fimmu.2018.00377","article-title":"Valproic acid combined with zoledronate enhance gammadelta t cell-mediated cytotoxicity against osteosarcoma cells via the accumulation of mevalonate pathway intermediates","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1006088","DOI":"10.1080\/2162402X.2015.1006088","article-title":"gammadelta T cells and epigenetic drugs: a useful merger in cancer immunotherapy?","volume":"4","author":"Bhat","year":"2015","journal-title":"Oncoimmunology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3389\/fimmu.2018.00800","article-title":"Improving the efficiency of vgamma9vdelta2 T-cell immunotherapy in cancer","volume":"9","author":"Hoeres","year":"2018","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.exphem.2009.04.008","article-title":"Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma","volume":"37","author":"Abe","year":"2009","journal-title":"Exp Hematol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00428-003-0784-4","article-title":"A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform","volume":"442","author":"Sipos","year":"2003","journal-title":"Virchows Arch"},{"key":"B53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2172-8-27","article-title":"A guide to modern statistical analysis of immunological data","volume":"8","author":"Genser","year":"2007","journal-title":"BMC Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00569\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T04:18:36Z","timestamp":1553660316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00569\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2019.00569"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00569","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"article-number":"569"}}